Cite

HARVARD Citation

    Alexander, T. et al. (n.d.). S1D:6 Targeting plasma cells and their precursors by immunoablation versus bortezomib plus rituximab in systemic lupus erythemtosus. Lupus science & medicine. pp. A4-A5. [Online]. 
  
Back to record